US regulator approves at-home Alzheimer’s drug from Eisai and Biogen

Aug 29, 2025 - 22:22

0 0

US regulator approves at-home Alzheimer’s drug from Eisai and Biogen

Go ahead for Leqembi shot by Food and Drug Administration could help revive two companies’ sluggish sales

What's Your Reaction?

Like 0

Dislike 0

Love 0

Funny 0

Angry 0

Sad 0

Wow 0

Related Posts

Ex-Sequoia partner closes in on $400mn European tech fund

Ex-Sequoia partner closes in on $400mn European tech fund

Jul 13, 2025 0 0

China falls for US-style bulk buying at Sam’s Club despite trade tensions

China falls for US-style bulk buying at Sam’s Club desp...

Jul 13, 2025 0 0

Wall Street expects glittering earnings despite trade war

Wall Street expects glittering earnings despite trade war

Jul 13, 2025 0 0

BCG earned more than $1mn for Gaza aid barge project

BCG earned more than $1mn for Gaza aid barge project

Jul 13, 2025 0 0

Trump threatens 30% tariffs on EU and Mexico from August 1

Trump threatens 30% tariffs on EU and Mexico from August 1

Jul 13, 2025 0 0

North Korea unconditionally backs Putin’s war in Ukraine during Lavrov visit

North Korea unconditionally backs Putin’s war in Ukrain...

Jul 13, 2025 0 0